CD8A and breast cancer: Similar observations were also made in other types of cancer: A large immunohistochemical study reported that high densities of FoxP3+ TIL were only indicative of improved survival in HER2+/estrogen receptor negative (ER-) breast cancer if they coincided with accumulations of CD8+ TIL.